Researchers argue that neurologists should integrate spiritual assessment into care to help patients with Parkinson’s and dementia find meaning.

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis ...

FIRST SITE INITIATION VISIT COMPLETED IN AUSTRALIA SARASOTA, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-tar ...

Discover why decades of research now challenge the BPD diagnosis — and how new models may offer clearer, less stigmatizing ways forward.

Callan JMB will Provide Independent Manufacturing Oversight and Governance as lodonal™ Undergoes Clinical Trials for Underserved Patient Population ...

New platform connects patients with licensed providers offering sermorelin under medical supervision, supported by a growing body of peer-reviewed research and an emerging community of clinicians and ...

SGT-003 in the INSPIRE DUCHENNE trial to date - - Robust microdystrophin expression with consistent mechanistic evidence of dystrophin associated protein complex ...

A pilot randomized trial of older adults with mild cognitive impairment given either daily low-dose lithium carbonate or placebo for 2 years met its feasibility target, according to results published ...

The California Science and Health Research Bond Act would restore funding to a broad range of life-saving scientific research ...

Psyence BioMed is executing its strategy from a position of financial stability. The Company is well capitalized, carries no corporate debt, and is supported by an experienced executive team advancing ...

The prescription drug leucovorin is getting a label update, though it’s not what that the US Food and Drug Administration suggested might be coming during a White House briefing in September, when ...

A sweeping review of previous research suggests commonly prescribed opioids often provide only modest pain relief and may increase side effect risk.